Please login to the form below

Not currently logged in
Email:
Password:

MSD/Roche expand hepatitis C partnership

MSD and Roche have signed a deal for the global promotion and marketing of Victrelis as part of a combination therapy for the hepatitis C virus

MSD (known as Merck within the US and Canada) and Roche have signed a deal for the global promotion and marketing of Victrelis as part of a combination therapy for the hepatitis C virus (HCV).

The deal follows the approval of the drug for marketing in the European Union, and expands upon a previous agreement between the two companies in May, 2011.

Under the revised terms, the two companies will work together in global markets, including Europe, Asia and Latin America, providing education for physicians and patients about HCV.

Previously, plans for promotion of the drug only covered the US, where the treatment was recently approved by the Food and Drug Administration.

Victrelis is intended for the treatment of chronic HCV, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.

It is an oral therapy that is taken three times a day with food. MSD acquired the drug as part of its 2009 takeover of Schering-Plough, which had brought the product through phase II development.

20th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics